PIPA520514

LGI4 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA520514-Each-of-1 In Stock ₹ 46,591.50

PIPA520514 - Each of 1

₹ 46,591.50

In Stock

Quantity

1

Base Price: ₹ 46,591.50

GST (18%): ₹ 8,386.47

Total Price: ₹ 54,977.97

Antigen

LGI4

Classification

Polyclonal

Conjugate

Unconjugated

Gene

LGI4

Gene Alias

clp; leucine rich repeat LGI family member 4; leucine-rich glioma inactivated protein 4; leucine-rich glioma-inactivated gene 4; leucine-rich glioma-inactivated protein 4; Leucine-rich repeat LGI family member 4; leucine-rich repeat LGI family, member 4; LGI1-like protein 3; LGI4; Lgil3; UNQ6515/PRO21485

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

163175, 243914, 361549

Content And Storage

Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C

Form

Liquid

Applications

Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

Q8K1S1, Q8N135

Gene Symbols

LGI4

Immunogen

A 17 amino acid peptide from near the carboxy terminus of human LGI4.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA520493

--

Img

Novus Biologicals

NB205541

--

Img

Novus Biologicals

NB204862

--

Img

Novus Biologicals

NB205690

--

Img

Thermo Scientific

PIPA521101

--

Img

Thermo Scientific

PIPA519994

--

Img

Novus Biologicals

NB483069

--

Img

Thermo Scientific

PIPA521061

--

Description

  • A suggested positive control is rat brain tissue lysate
  • PA5-20514 can be used with blocking peptide PEP-0634
  • The leucine-rich, glioma inactivated gene 4 (LGI4) is a member of the LGI family in which LGI1 is the exemplar
  • The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors
  • LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms
  • Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI4 have not been found to be associated with ADTLE
  • However, the LGI4 gene is located in a region linked to benign familial infantile convulsions
  • Further study revealed that a GC-to-AT polymorphism was correlated with childhood absence epilepsy
  • Other studies showed that decreasing LGI4 expression in cultured cells inhibits myelination, indicating that LGI4 may play a role in neural development.